Health care stocks rose in Wednesday's pre-bell activity with the Health Care Select Sector SPDR Fund (XLV) 0.3% higher and the iShares Biotechnology ETF (IBB) up 1.4% recently.
Progyny (PGNY) shares fell 13% after the company lowered its 2024 guidance for adjusted earnings per share and revenue.
Guardian Pharmacy Services (GRDN) shares were down nearly 10% after the company reported a Q3 loss of $2 per share.
Amgen (AMGN) shares rose past 3% after the company said it found no connection between its potential once-monthly weight-loss injection MariTide and bone density loss. The statement was issued in response to media reports that some analysts voiced concern that an early-stage trial of the potential weight-loss drug suggested it caused bone-density losses as a side effect.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。